Disclosed is a novel compound which has a potent antibacterial activity on a gram-negative bacterium (e.g., Pseudomonas aeruginosa) or a drug-resistant mutant thereof relying on its and LpxC inhibitory activity, and which is therefore useful as a pharmaceutical agent. Specifically disclosed is a hydroxamic acid derivative represented by the general formula (1) below or a pharmaceutically acceptable salt thereof.